Molbio Diagnostics Limited Peer Comparison
MOLBIO · Healthcare · Current price ₹1,503
Peers tracked
11
Molbio Diagnostics Limited P/E
117.2x
Sector
Healthcare
Molbio Diagnostics Limited vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹8,526 | 58.8x | 1,22,440 |
| Max Healthcare Institute Limited | ₹947.1 | 69.4x | 91,979 |
| Manipal Health Enterprises Limited | ₹681.4 | 106.4x | 89,446 |
| Aster DM Quality Care Limited | ₹722.5 | 184.3x | 62,952 |
| Fortis Healthcare Limited | ₹764 | 63.6x | 57,754 |
| Global Health Limited | ₹1,454 | 71.1x | 39,083 |
| Narayana Hrudayalaya Ltd. | ₹1,860.4 | 47.8x | 38,062 |
| Dr. Lal Path Labs Ltd. | ₹1,993 | 58.9x | 33,431 |
| Krishna Institute of Medical Sciences Limited | ₹729.65 | 166.9x | 30,644 |
| Syngene International Limited | ₹444.3 | 70.2x | 17,951 |
| Molbio Diagnostics Limited | ₹1,493.2 | 106.0x | 17,226 |
Molbio Diagnostics Limited versus its peers
Molbio Diagnostics Limited operates in the Healthcare space alongside 11 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of 117.2x may be cheap in one industry and expensive in another.
More on Molbio Diagnostics Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.

